The expression levels of ATXN3 | chr14:92526779, LOC100130744 | chr5:14716392, METTL2A | chr17:60528133, PEX26 | chr22:18572607 and UGGT1 | chr2:128949284 in tumour tissues were significantly higher than those in normal tissues (p < 0.05) (Figure 7A–I). This evidence concerns the gene METTL2A and neoplasm.